Literature DB >> 23415536

Genetic characterization of antimicrobial resistance in coagulase-negative staphylococci from bovine mastitis milk.

Yvonne Frey1, Joan Peña Rodriguez1, Andreas Thomann1, Sybille Schwendener1, Vincent Perreten2.   

Abstract

Coagulase-negative staphylococci (CNS; n=417) were isolated from bovine milk and identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Nineteen different species were identified, and Staphylococcus xylosus, Staphylococcus chromogenes, Staphylococcus haemolyticus, and Staphylococcus sciuri were the most prevalent species. Resistance to oxacillin (47.0% of the isolates), fusidic acid (33.8%), tiamulin (31.9%), penicillin (23.3%), tetracycline (15.8%), streptomycin (9.6%), erythromycin (7.0%), sulfonamides (5%), trimethoprim (4.3%), clindamycin (3.4%), kanamycin (2.4%), and gentamicin (2.4%) was detected. Resistance to oxacillin was attributed to the mecA gene in 9.7% of the oxacillin-resistant isolates. The remaining oxacillin-resistant CNS did not contain the mecC gene or mecA1 promoter mutations. The mecA gene was detected in Staphylococcus fleurettii, Staphylococcus epidermidis, Staph. haemolyticus, and Staph. xylosus. Resistance to tetracycline was attributed to the presence of tet(K) and tet(L), penicillin resistance to blaZ, streptomycin resistance to str and ant(6)-Ia, and erythromycin resistance to erm(C), erm(B), and msr. Resistance to tiamulin and fusidic acid could not be attributed to an acquired resistance gene. In total, 15.1% of the CNS isolates were multidrug resistant (i.e., resistant to 2 or more antimicrobials). The remaining CNS isolates were susceptible to antimicrobials commonly used in mastitis treatment. Methicillin-resistant CNS isolates were diverse, as determined by mecA gene sequence analysis, staphylococcal cassette chromosome mec typing, and pulsed-field gel electrophoresis. Arginine catabolic mobile element types 1 and 3 were detected in both methicillin-resistant and methicillin-susceptible Staph. epidermidis and were associated with sequence types ST59 and ST111. Because this study revealed the presence of multidrug-resistant CNS in a heterogeneous CNS population, we recommend antibiogram analysis of CNS in persistent infections before treatment with antimicrobials.
Copyright © 2013 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23415536     DOI: 10.3168/jds.2012-6091

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  31 in total

1.  The new macrolide-lincosamide-streptogramin B resistance gene erm(45) is located within a genomic island in Staphylococcus fleurettii.

Authors:  Juliette R K Wipf; Sybille Schwendener; Jesper Boye Nielsen; Henrik Westh; Vincent Perreten
Journal:  Antimicrob Agents Chemother       Date:  2015-03-16       Impact factor: 5.191

2.  Relationship between L-lactate dehydrogenase and multidrug resistance in Staphylococcus xylosus.

Authors:  Zhongwei Yuan; Jinpeng Wang; Ruixiang Che; Bello-Onaghise God'spower; Yonghui Zhou; Chunliu Dong; Lu Li; Mingri Chen; Nsabimana Eliphaz; Xin Liu; Yanhua Li
Journal:  Arch Microbiol       Date:  2021-12-28       Impact factor: 2.552

3.  The novel macrolide-Lincosamide-Streptogramin B resistance gene erm(44) is associated with a prophage in Staphylococcus xylosus.

Authors:  Juliette R K Wipf; Sybille Schwendener; Vincent Perreten
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

4.  New Macrolide-Lincosamide-Streptogramin B Resistance Gene erm(48) on the Novel Plasmid pJW2311 in Staphylococcus xylosus.

Authors:  Juliette R K Wipf; Matthew C Riley; Stephen A Kania; David A Bemis; Sabrina Andreis; Sybille Schwendener; Vincent Perreten
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

5.  Typing of mecD Islands in Genetically Diverse Methicillin-Resistant Macrococcus caseolyticus Strains from Cattle.

Authors:  Sybille Schwendener; Aurélien Nigg; Alexandra Collaud; Gudrun Overesch; Sonja Kittl; Nathita Phumthanakorn; Vincent Perreten
Journal:  Appl Environ Microbiol       Date:  2019-09-17       Impact factor: 4.792

6.  Staphylococcus xylosus Cystitis and Struvite Urolithiasis in Nude Mice Implanted with Sustained-release Estrogen Pellets.

Authors:  Kenneth J Salleng; Carissa P Jones; Kelli L Boyd; Donna J Hicks; Michelle M Williams; Rebecca S Cook
Journal:  Comp Med       Date:  2018-07-17       Impact factor: 0.982

7.  Methicillin-Resistant Staphylococcus aureus Strains in Swiss Pigs and Their Relation to Isolates from Farmers and Veterinarians.

Authors:  Sonja Kittl; Isabelle Brodard; Dagmar Heim; Patrizia Andina-Pfister; Gudrun Overesch
Journal:  Appl Environ Microbiol       Date:  2020-02-18       Impact factor: 4.792

8.  Evolutionary Origin of the Staphylococcal Cassette Chromosome mec (SCCmec).

Authors:  Joana Rolo; Peder Worning; Jesper Boye Nielsen; Rory Bowden; Ons Bouchami; Peter Damborg; Luca Guardabassi; Vincent Perreten; Alexander Tomasz; Henrik Westh; Hermínia de Lencastre; Maria Miragaia
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

9.  Prevalence and Risk Factors of Mastitis and Isolation, Identification and Antibiogram of Staphylococcus Species from Mastitis Positive Zebu Cows in Toke Kutaye, Cheliya, and Dendi Districts, West Shewa Zone, Oromia, Ethiopia.

Authors:  Dimshasha Tolera Dabele; Bizunesh Mideksa Borena; Petros Admasu; Endrias Zewdu Gebremedhin; Lencho Megersa Marami
Journal:  Infect Drug Resist       Date:  2021-03-12       Impact factor: 4.003

10.  Phenotypic and genotypic methods for identification of slime layer production, efflux pump activity, and antimicrobial resistance genes as potential causes of the antimicrobial resistance of some mastitis pathogens from farms in Menoufia, Egypt.

Authors:  Mohamed Sabry Abd Elraheam Elsayed; Tamer Roshdey; Ahmed Salah; Reda Tarabees; Gamal Younis; Doaa Eldeep
Journal:  Mol Biol Rep       Date:  2019-10-03       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.